Medicare Advantage 2027 Payment Rates: Why a 2.48% Increase Actually Delivers 4.98% More Revenue to Plans

The 2.48% Medicare Advantage rate increase for 2027 isn't the number that matters for your contract negotiations. When accounting for risk score trends, plans will see a 4.98% revenue boost next year.

This gap between the headline rate and actual plan revenue creates a negotiating advantage that most providers haven't recognized yet. While your finance team prepares for modest 2.5% discussions, Medicare Advantage plans are planning around nearly double that increase.

The Math Behind Plan Windfalls

CMS projects the net average increase will deliver over $13 billion in additional Medicare Advantage payments to plans. The difference between 2.48% and 4.98% comes from risk score methodology changes that amplify plan revenues beyond the base rate adjustment.

Starting in 2027, CMS will exclude diagnosis information from unlinked chart review records from risk score calculations. This technical change removes some of the documentation burden that previously constrained risk score growth, effectively allowing plans to capture higher reimbursements for the same patient populations.

The Contract Year 2027 final rule also introduces changes to quality bonus payments and Star Ratings that create additional revenue opportunities for well-performing plans.

Why This Reshapes Your Contract Position

Medicare Advantage plans entering 2027 negotiations with a 4.98% revenue increase have substantially more room to absorb provider rate increases than the 2.48% headline suggests. For surgery centers and medical groups heavily dependent on Medicare Advantage volume, this represents the strongest negotiating position in years.

The timing creates particular leverage for providers whose contracts come up for renewal in early 2027. Plans will have locked in their higher CMS payments but may not have adjusted their provider rate assumptions accordingly. Revenue cycle leaders should audit current Medicare Advantage contracts to identify renewal dates that align with this payment boost.

For clinicians with ownership stakes in surgery centers, this revenue differential directly impacts facility profitability. A plan receiving 4.98% more revenue while negotiating provider increases based on 2.48% creates margin expansion that flows to the bottom line.

What to Monitor Through 2026

Track how your largest Medicare Advantage plans communicate rate increases to their provider networks. Plans that reference the 2.48% figure without acknowledging risk score impacts may be positioning for below-market negotiations.

Watch for changes in prior authorization patterns as plans adjust to new risk score methodologies. Some plans may tighten utilization management to offset higher risk payments, while others may ease restrictions to maintain provider relationships during a revenue-positive cycle.

Monitor CMS guidance on risk adjustment implementation throughout 2026. Technical clarifications on the unlinked chart review exclusion could further amplify or moderate the revenue impact for specific plan types.

RCM directors should also track how plans modify their Star Ratings strategies in response to the new quality bonus structure. Plans investing heavily in Star Ratings improvement may offer more favorable provider terms to ensure network stability during their quality initiatives.